EUCTR2007-002588-28-IT进行中（未招募）不适用
PHASE II STUDY OF METRONOMIC ORAL VINORELBINE IN ADVANCED BREASTCANCER - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Histologically or cytologically proven diagnosis breast cancer with evidence of 1) unresectable, locally recurrent, or 2) metastatic disease. At least one bidimensionally measurable lesion adequately measured by imaging procedure (See section 15). Prior chemotherapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patient with T4d disease inflammatory cancer as unique disease, symptomatic lung lymphangitis.
研究者
相似试验
进行中（未招募）
不适用
Phase II study of metronomic oral Vinorelbine plus Bevacizumab as first line treatment for metastatic breast cancer patients - NDMetastatic breast cancerEUCTR2010-022183-12-ITISTITUTO EUROPEO DI ONCOLOGIA
进行中（未招募）
1 期
A clinical study comparing the combination of oral chemotherapy medications vinorelbine plus cyclophosphamide and capecitabine taken orally at lower doses on a continuous regular schedule with paclitaxel given by injection once a week in patients with advanced breast cancer or breast cancer that has spread to other body systems.EUCTR2016-002200-39-ITInternational Breast Cancer Study Group (IBCSG)160
进行中（未招募）
1 期
Phase II study evaluating oral vinorelbine as a single agent in patients with hormone receptor breast cancer with bone metastases previously treated by a hormone therapyBreast cancer with bone metastases previously treated by a hormone therapy.MedDRA version: 12.1Level: LLTClassification code 10027475Term: <Manually entered code. Term in E.1.1>EUCTR2009-014497-18-FRPIERRE FABRE MEDICAMENT66
进行中（未招募）
不适用
Phase II study evaluating oral vinorelbine as a single agent in patients with hormone receptor breast cancer with bone metastases previously treated by a hormone therapyBreast cancer with bone metastases previously treated by a hormone therapy.MedDRA version: 13.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-014497-18-ATPIERRE FABRE MEDICAMENT66
进行中（未招募）
不适用
Phase II study evaluating oral vinorelbine as a single agent in patients with hormone receptor positive breast cancer with bone metastases previously treated by a hormone therapy. - NDEUCTR2009-014497-18-ITPIERRE FABRE MEDICAMENT66